These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34591069)

  • 1. Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors.
    Bateni SB; Coburn NG; Law CHL; Singh S; Myrehaug S; Assal A; Hallet J
    JAMA Oncol; 2021 Nov; 7(11):1718-1720. PubMed ID: 34591069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
    Kamp K; Damhuis RA; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors.
    Kauffmann RM; Wang L; Phillips S; Idrees K; Merchant NB; Parikh AA
    Ann Surg Oncol; 2014 Oct; 21(11):3422-8. PubMed ID: 25059786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.
    Stemann Lau T; Dam G; Jepsen P; Grønbæk H; Krogh K; Gregersen T
    Neuroendocrinology; 2018; 107(3):280-283. PubMed ID: 30092588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
    Gálffy G
    Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors.
    Verrico M; Rossi L; Tomao S; Colonna M; Vici P; Tomao F
    Oncology; 2020; 98(1):10-15. PubMed ID: 31505502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.
    Eriksson J; Norlén O; Ögren M; Garmo H; Ihre-Lundgren C; Hellman P
    Scand J Surg; 2021 Mar; 110(1):44-50. PubMed ID: 31587594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
    Akamatsu S; Inoue T; Ogawa O; Gleave ME
    Int J Urol; 2018 Apr; 25(4):345-351. PubMed ID: 29396873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine Cancer of the Prostate.
    Kránitz N; Szepesváry Z; Kocsis K; Kullmann T
    Pathol Oncol Res; 2020 Jul; 26(3):1447-1450. PubMed ID: 31414399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon.
    Kesrouani C; Ghorra C; Rassy M; Kourie HR; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2579-81. PubMed ID: 27268633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study.
    Massironi S; Campana D; Pusceddu S; Albertelli M; Faggiano A; Panzuto F; Smiroldo V; Andreasi V; Rossi RE; Maggio I; Torchio M; Dotto A; Modica R; Rinzivillo M; Carnaghi C; Partelli S; Fanetti I; Lamberti G; Corti F; Ferone D; Colao A; Annibale B; Invernizzi P; Falconi M;
    Dig Liver Dis; 2021 Mar; 53(3):367-374. PubMed ID: 33645508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary malignancies in patients with neuroendocrine tumors.
    Reina JJ; Serrano R; Codes M; Jiménez E; Bolaños M; Gonzalez E; Sevilla I
    Clin Transl Oncol; 2014 Oct; 16(10):921-6. PubMed ID: 24788817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study.
    Bojesen RD; Andersson M; Riis LB; Nielsen OH; Jess T
    J Gastroenterol; 2016 Sep; 51(9):891-9. PubMed ID: 26847562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.
    Clift AK; Drymousis P; Al-Nahhas A; Wasan H; Martin J; Holm S; Frilling A
    Neuroendocrinology; 2015; 102(1-2):26-32. PubMed ID: 25824138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary neuroendocrine/carcinoid tumors: a review article.
    Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
    Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
    Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
    Garcia-Carbonero R
    Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
    [No Abstract]   [Full Text] [Related]  

  • 20. Large-cell neuroendocrine cancer of the colon following rituximab-based lymphoma treatment.
    Freeman HJ; Kwan PW; Webber D
    Can J Gastroenterol; 2012 Jan; 26(1):12-3. PubMed ID: 22288066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.